ELANE and cystic fibrosis: The occasional dosing of A1AT in critically ill patients with infections may mitigate consequences leading to emphysema [27] and symptoms of CF patients with elevated neutrophil elastase concentrations that cause the deterioration of the airway tissue [28,29].